These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35851589)

  • 1. Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease.
    Wilkinson TJ; Miksza J; Zaccardi F; Lawson C; Nixon AC; Young HML; Khunti K; Smith AC
    J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2426-2435. PubMed ID: 35851589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frailty and Cardiovascular Outcomes in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Hannan M; Chen J; Hsu J; Zhang X; Saunders MR; Brown J; McAdams-DeMarco M; Mohanty MJ; Vyas R; Hajjiri Z; Carmona-Powell E; Meza N; Porter AC; Ricardo AC; Lash JP;
    Am J Kidney Dis; 2024 Feb; 83(2):208-215. PubMed ID: 37741609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
    Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Carbamylation and the Risk of ESKD in Patients with CKD.
    Kalim S; Zhao S; Tang M; Rhee EP; Allegretti AS; Nigwekar S; Karumanchi SA; Lash JP; Berg AH
    J Am Soc Nephrol; 2023 May; 34(5):876-885. PubMed ID: 36757153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study.
    Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    PLoS Med; 2016 Sep; 13(9):e1002128. PubMed ID: 27648564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frailty in chronic kidney disease: challenges in nephrology practice. A review of current literature.
    Kennard A; Glasgow N; Rainsford S; Talaulikar G
    Intern Med J; 2023 Apr; 53(4):465-472. PubMed ID: 35353436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
    Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V
    BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the relationship between FRailty And Quality of LIfe in patients with heart faiLure and CKD (FRAIL study).
    McNally T; Tumelty E; Chung I; Hussain S; Mookerjee S; Ali MA; Anderson L; Rosano G; Banerjee D
    ESC Heart Fail; 2024 Jun; 11(3):1411-1421. PubMed ID: 38320815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.
    Stack AG; Johnson ME; Blak B; Klein A; Carpenter L; Morlock R; Maguire AR; Parsons VL
    BMJ Open; 2019 Aug; 9(8):e031550. PubMed ID: 31462487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep Quality and Sleep Duration with CKD are Associated with Progression to ESKD.
    Yamamoto R; Shinzawa M; Isaka Y; Yamakoshi E; Imai E; Ohashi Y; Hishida A;
    Clin J Am Soc Nephrol; 2018 Dec; 13(12):1825-1832. PubMed ID: 30442866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of sarcopenia with mortality and end-stage renal disease in those with chronic kidney disease: a UK Biobank study.
    Wilkinson TJ; Miksza J; Yates T; Lightfoot CJ; Baker LA; Watson EL; Zaccardi F; Smith AC
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):586-598. PubMed ID: 33949807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
    Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between sarcopenia and frailty in elderly patients with chronic kidney disease.
    Wang C; Guo X; Xu X; Liang S; Wang W; Zhu F; Wang S; Wu J; Zhang L; Sun X; Chen X; Cai G;
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1855-1864. PubMed ID: 37300354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of frailty in nephrology-referred patients with CKD.
    Roshanravan B; Khatri M; Robinson-Cohen C; Levin G; Patel KV; de Boer IH; Seliger S; Ruzinski J; Himmelfarb J; Kestenbaum B
    Am J Kidney Dis; 2012 Dec; 60(6):912-21. PubMed ID: 22770927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association among kidney function, frailty, and oral function in patients with chronic kidney disease: a cross-sectional study.
    Kosaka S; Ohara Y; Naito S; Iimori S; Kado H; Hatta T; Yanishi M; Uchida S; Tanaka M
    BMC Nephrol; 2020 Aug; 21(1):357. PubMed ID: 32819288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
    Chinnadurai R; Flanagan E; Jayson GC; Kalra PA
    BMC Nephrol; 2019 Oct; 20(1):380. PubMed ID: 31640599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease.
    Faucon AL; Flamant M; Metzger M; Boffa JJ; Haymann JP; Houillier P; Thervet E; Vrtovsnik F; Stengel B; Geri G; Vidal-Petiot E;
    Kidney Int; 2019 Oct; 96(4):1020-1029. PubMed ID: 31477263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.